M&L Healthcare Investments
M&L Healthcare Investments is a privately held Singapore-based investment entity that provides financial assistance to healthcare businesses, operating with a lean 1-10 person team. Its sole documented activity is participation in Endovascular Engineering's $80M Series C round.
- Company typePrivate
- Founded-
- HeadquartersSingapore, Singapore
- Headcount1–10
- GTM typeB2B
- OfferingServices
What M&L Healthcare Investments does
M&L Healthcare Investments is a privately held, Singapore-based investment entity focused on the healthcare sector. According to available firmographic data, the firm provides and offers financial assistance to businesses in the healthcare industry, operating with a lean team of 1-10 employees. Its public footprint is minimal: the company website (mnlhealthcare.com) presents only a loading/verification page, and there are no disclosed products, services, pricing models, management team bios, or operational geographies in the available source material.
The company's only documented strategic activity is its participation as a financial investor in Endovascular Engineering's oversubscribed $80 million Series C funding round, announced on 2026-04-07. In that transaction, M&L Healthcare Investments joined co-leads Gilde Healthcare and Norwest, alongside existing investors Santé Ventures, S3 Ventures, 415 Capital, and Panakès Partners. Endovascular Engineering is a Menlo Park-based commercial-stage medical technology company commercializing the Hēlo Thrombectomy Platform for pulmonary embolism treatment, with $137M in total financing raised across rounds. M&L Healthcare Investments' role in the syndicate is as a participant investor, not a lead.
Key data gaps materially limit any deeper characterization: ownership structure, AUM, fund vintage, LP base, fee economics, prior portfolio history, and team composition are all undisclosed. The firm appears to be either a small family office, holding entity, or emerging healthcare-focused investment vehicle, but no source material supports a more definitive classification.
M&L Healthcare Investments firmographics
Firmographics- Name
- M&L Healthcare Investments
- Website
- https://mnlhealthcare.com
- Company type
- Private
- Headcount range
- 1–10 employees
- Short description
- M&L Healthcare Investments is a privately held Singapore-based investment entity that provides financial assistance to healthcare businesses, operating with a lean 1-10 person team. Its sole documented activity is participation in Endovascular Engineering's $80M Series C round.
- Ownership category
- akta.pro rank
M&L Healthcare Investments industry classification
Industry- Product category
- Healthcare Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Healthcare & Life Sciences Growth Equity (FSANACAB)
- akta.pro secondary industry
- Late-Stage Venture Capital (Series C+) (FSANAAAC)
Keywords
Where M&L Healthcare Investments is headquartered
LocationHeadquarters
- HQ city
- Singapore
- HQ country
- Singapore
- HQ region
- Asia
Markets served
M&L Healthcare Investments business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations
M&L Healthcare Investments product offering
Product offeringCore offering
M&L Healthcare Investments provides financial capital to privately held businesses in the healthcare industry, participating as a financial investor in equity funding rounds for healthcare and medical technology companies. The firm's evidenced activity is co-investment in late-stage venture rounds, including a $80 million Series C for Endovascular Engineering in April 2026 alongside specialist healthcare investors.
Differentiator
Problem solved
Functional benefit
Companies that use M&L Healthcare Investments
Customer profileIdeal customer profiles1 record
M&L Healthcare Investments technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
M&L Healthcare Investments partnerships and signals
Strategic signalScale indicators2 records
Recent moves2 records
Expansion highlights2 records
M&L Healthcare Investments competitors and assessment
Company assessmentDirect peers
- Gilde Healthcare: Specialized European healthcare and life sciences investor; co-led the Endovascular Engineering Series C alongside M&L Healthcare Investments. Directly comparable as a healthcare-focused growth investor with prior success in the VTE category (Inari Medical).
- Norwest: Venture and growth equity firm investing across healthcare and technology; co-led the Endovascular Engineering Series C with M&L Healthcare Investments. Comparable as a late-stage healthcare investor participating in commercial-stage medtech rounds.
- Santé Ventures: Healthcare-focused venture capital firm; existing investor in Endovascular Engineering that participated alongside M&L Healthcare Investments in the Series C. Directly comparable as a healthcare-specialist VC.
- 415 Capital: Medtech-focused venture capital firm; existing investor in Endovascular Engineering that participated alongside M&L Healthcare Investments. Highly comparable given its narrow medtech specialization.
- Panakès Partners: European venture capital firm investing in medtech and healthcare innovation; co-investor with M&L Healthcare Investments in Endovascular Engineering. Comparable as a medtech-focused investor.
- S3 Ventures: Texas-based healthcare-focused venture capital firm; existing investor in Endovascular Engineering that participated alongside M&L Healthcare Investments. Comparable healthcare-specialist VC.
Regional players
- CBC Group: Singapore-headquartered healthcare-dedicated investment firm; comparable as an Asia-based healthcare investor operating in private markets, though with substantially greater scale than M&L Healthcare Investments.
- Quadria Capital: APAC-focused healthcare private equity firm; comparable as a regional healthcare-specialist investor, though typically operating at growth/buyout stages rather than venture.
Broad incumbents
- OrbiMed: One of the largest healthcare-dedicated investment firms globally; comparable as a healthcare-specialist investor across stages, though with much greater AUM and broader sector coverage than M&L Healthcare Investments.
- Novo Holdings: Holding company of the Novo Nordisk Foundation with major healthcare and life sciences investment activities; comparable as a healthcare-focused institutional investor with global reach, though at substantially larger scale.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat1 record
Key risks5 records
Key highlights5 records
Customer concentration
M&L Healthcare Investments financial estimates
Financial estimateRevenue estimate
Valuation estimate
M&L Healthcare Investments leadership team
Management profileNumber of profiles
M&L Healthcare Investments funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
M&L Healthcare Investments M&A and investment
M&A and investmentM&A
Investments9 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about M&L Healthcare Investments
What does M&L Healthcare Investments do?
M&L Healthcare Investments provides financial capital to privately held businesses in the healthcare industry, participating as a financial investor in equity funding rounds for healthcare and medical technology companies. The firm's evidenced activity is co-investment in late-stage venture rounds, including a $80 million Series C for Endovascular Engineering in April 2026 alongside specialist healthcare investors.
When was M&L Healthcare Investments founded?
M&L Healthcare Investments was founded in -1. It employs 1 to 10 people.
Where is M&L Healthcare Investments based?
M&L Healthcare Investments is headquartered in Singapore, Singapore, in the Asia region.
Who are M&L Healthcare Investments's main competitors?
Direct peers on record are Gilde Healthcare, Norwest, Santé Ventures, 415 Capital, Panakès Partners and S3 Ventures. Regional players are CBC Group and Quadria Capital. Broad incumbents are OrbiMed and Novo Holdings.
Does M&L Healthcare Investments have an API?
No public API is recorded for M&L Healthcare Investments.
What industry is M&L Healthcare Investments in?
M&L Healthcare Investments's product category is Healthcare Venture Capital. Its primary akta.pro industry code is FSANACAB, Healthcare & Life Sciences Growth Equity, with a secondary code of FSANAAAC, Late-Stage Venture Capital (Series C+). Its NAICS code is 523940 and its SIC code is 6282.